ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 /Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company ...

In 2019, a meta-analysis suggested that the risk of coronary morbidity was 30% higher among Sjögren's patients than it was ...

Chonnam National University Hospital succeeded in introducing Impella for the first time in the coun... Chonnam National ...

Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...

ASCVD Risk Estimator Plus and PREVENT calculator would have classified many patients as low risk 48 hours before myocardial infarction.

A study finds target lesion failure in 1 in 5 patients with STEMI within 10 years of primary percutaneous coronary ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

A man in his 50s recently underwent a health screening at Gangbuk Samsung Hospital’s Comprehensive Health Screening Center in Jung-gu, Seoul, and was urgently transferred to the emergency room.

Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...

Invasive epicardial coronary physiologic assessment is increasingly performed to evaluate the hemodynamic significance of ...

For patients with acute coronary syndrome, targeted vitamin D3 supplementation is associated with a reduced risk for follow-up myocardial infarction.